Laspobres, Jye Rileigh A.
HRN: 15-76-31 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/06/2024
04/12/2024
IVT
490mg
Q6hrs
Pcap B
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes